This pooled analysis of the 2019 to 2024 Medical Expenditure Panel Survey (MEPS) evaluated health-related quality of life, healthcare utilization, and healthcare expenditures among US adults with myocardial infarction (MI), heart failure (HF), both conditions, or neither. The investigators aimed to quantify the physical and mental quality-of-life burden using a standardized instrument and to describe patterns of healthcare use and spending across these mutually exclusive groups.
The study combined MEPS survey data from 2019–2024 for adults aged 18 years and older. Respondents were categorized into four mutually exclusive groups: MI without HF, HF without MI, both MI and HF, and neither condition. Survey weighting was used to produce national estimates representing US adults.
Quality of life was assessed using the Veterans RAND 12-item (VR-12) instrument reported as T scores (mean 50, SD 10). The VR-12 yields physical and mental component summary scores; higher scores indicate better health-related quality of life. A difference of 3 T-score points was prespecified as the minimally important difference. The authors applied survey-weighted linear regression models adjusted for demographics, socioeconomic factors, and comorbidity to estimate adjusted differences in scores across cardiac groups.
The pooled analytic sample consisted of 79,853 respondents, representing 253.8 million US adults. Within that weighted population, 4.2% of adults (3,340 respondents) had MI alone, 0.6% (480 respondents) had HF alone, and 0.3% (236 respondents) had both MI and HF. The remaining respondents were classified as having neither condition.
Unadjusted VR-12 physical component T scores differed markedly across groups. Adults with HF alone had the lowest unadjusted physical score (33.2), followed by MI alone (39.1), while adults with neither condition had a group mean of 50.5.
After adjustment for demographic, socioeconomic, and comorbidity covariates, physical component scores remained substantially lower in cardiac groups compared with adults without MI or HF. The adjusted reductions were:
Each of these adjusted differences exceeded the prespecified minimally important threshold of 3 points, indicating clinically meaningful decrements in physical quality of life, with the largest decrement observed for HF alone.
Unadjusted and adjusted mental component scores were lower in the cardiac groups compared with adults without either condition, but the magnitude of change was smaller than for the physical component. Adjusted differences in mental component T scores were:
All adjusted mental-score differences were below the 3-point minimally important threshold. The authors additionally reported that adults with both conditions did not differ meaningfully from those with HF alone (difference 0.58 points; 95% CI, −1.76 to 2.92).
The analysis found that measures of healthcare utilization—specifically emergency department visits and inpatient discharges—were higher in all cardiac groups than in adults without MI or HF. Utilization was highest among adults with both MI and HF. Specific utilization counts or rates were presented in the MEPS-derived weighted estimates; the authors emphasize a consistent increase in utilization across groups with cardiac disease.
Annual healthcare expenditures were substantially higher in cardiac groups compared with adults without MI or HF. The highest reported mean annual expenditure was for adults with both MI and HF, reaching $37,198, compared with $7,845 for adults with neither condition. Expenditure estimates were based on MEPS survey-weighted financial data.
In this nationally representative survey analysis, declines in physical quality of life tracked across cardiac groups and were driven largely by heart failure rather than by prior MI. While mental quality-of-life differences were present in unadjusted comparisons, the adjusted reductions in mental scores were small and did not meet the prespecified minimally important threshold. Healthcare utilization and spending were elevated in all cardiac groups and were greatest when MI and HF coexisted.
The authors declared no competing interests. They stated that all relevant ethical guidelines were followed and that participant consent procedures were in place. The report notes that data are available on request. The manuscript was posted as a medRxiv preprint; details such as additional subgroup analyses or sensitivity checks were not reported in the provided source text.